Literature DB >> 29226580

A novel truncating variant within exon 7 of KAT6B associated with features of both Say-Barber-Bieseker-Young-Simpson syndrome and genitopatellar syndrome: Further evidence of a continuum in the clinical spectrum of KAT6B-related disorders.

Giuseppe Marangi1, Marilena C Di Giacomo2, Serena Lattante1, Daniela Orteschi1, Sara Patrizi1, Paolo N Doronzio1, Francesco N Riviello2, Alessandro Vaisfeld1, Silvia Frangella1, Marcella Zollino1.   

Abstract

KAT6B sequence variants have been identified in both patients with the Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and in the genitopatellar syndrome (GPS). In SBBYSS, they were reported to affect mostly exons 16-18 of KAT6B, and the predicted mechanism of pathogenesis was haploinsufficiency or a partial loss of protein function. Truncating variants in KAT6B leading to GPS appear to cluster within the proximal portion of exon 18, associated with a dominant-negative effect of the mutated protein, most likely. Although SBBYSS and GPS have been initially considered allelic disorders with distinctive genetic and clinical features, there is evidence that they represent two ends of a spectrum of conditions referable as KAT6B-related disorders. We detected a de novo truncating variant within exon 7 of KAT6B in a 8-year-old female who presented with mild intellectual disability, facial dysmorphisms highly consistent with SBBYSS, and skeletal anomalies including exostosis, that are usually considered component manifestations of GPS. Following the clinical diagnosis driven by the striking facial phenotype, we analyzed the KAT6B gene by NGS techniques. The present report highlights the pivotal role of clinical genetics in avoiding clear-cut genotype-phenotype categories in syndromic forms of intellectual disability. In addition, it further supports the evidence that a continuum exists within the clinical spectrum of KAT6B-associated disorders.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  KAT6B-related disorders; focused exome sequencing; skeletal anomalies

Mesh:

Substances:

Year:  2017        PMID: 29226580     DOI: 10.1002/ajmg.a.38571

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Delineation of a Phenotype Caused by a KAT6B Missense Variant Not Resembling Say-Barber-Biesecker-Young-Simpson and Genitopatellar Syndromes.

Authors:  Naoto Nishimura; Yumi Enomoto; Tatsuro Kumaki; Hiroaki Murakami; Azusa Ikeda; Tomohide Goto; Kenji Kurosawa
Journal:  Mol Syndromol       Date:  2022-02-02

Review 2.  Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants.

Authors:  Li Xin Zhang; Gabrielle Lemire; Claudia Gonzaga-Jauregui; Sirinart Molidperee; Carolina Galaz-Montoya; David S Liu; Alain Verloes; Amelle G Shillington; Kosuke Izumi; Alyssa L Ritter; Beth Keena; Elaine Zackai; Dong Li; Elizabeth Bhoj; Jennifer M Tarpinian; Emma Bedoukian; Mary K Kukolich; A Micheil Innes; Grace U Ediae; Sarah L Sawyer; Karippoth Mohandas Nair; Para Chottil Soumya; Kinattinkara R Subbaraman; Frank J Probst; Jennifer A Bassetti; Reid V Sutton; Richard A Gibbs; Chester Brown; Philip M Boone; Ingrid A Holm; Marco Tartaglia; Giovanni Battista Ferrero; Marcello Niceta; Maria Lisa Dentici; Francesca Clementina Radio; Boris Keren; Constance F Wells; Christine Coubes; Annie Laquerrière; Jacqueline Aziza; Charlotte Dubucs; Sheela Nampoothiri; David Mowat; Millan S Patel; Ana Bracho; Francisco Cammarata-Scalisi; Alper Gezdirici; Alberto Fernandez-Jaen; Natalie Hauser; Yuri A Zarate; Katherine A Bosanko; Klaus Dieterich; John C Carey; Jessica X Chong; Deborah A Nickerson; Michael J Bamshad; Brendan H Lee; Xiang-Jiao Yang; James R Lupski; Philippe M Campeau
Journal:  Genet Med       Date:  2020-05-19       Impact factor: 8.822

Review 3.  Reprogramming of the epigenome in neurodevelopmental disorders.

Authors:  Khadija D Wilson; Elizabeth G Porter; Benjamin A Garcia
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-10-02       Impact factor: 8.697

4.  KAT6B-related disorder in a patient with a novel frameshift variant (c.3925dup).

Authors:  Yo Hamaguchi; Mikihiro Aoki; Satoshi Watanabe; Hiroyuki Mishima; Koh-Ichiro Yoshiura; Hiroyuki Moriuchi; Sumito Dateki
Journal:  Hum Genome Var       Date:  2019-12-13

5.  Novel variants in KAT6B spectrum of disorders expand our knowledge of clinical manifestations and molecular mechanisms.

Authors:  Megan Yabumoto; Jessica Kianmahd; Meghna Singh; Maria F Palafox; Angela Wei; Kathryn Elliott; Dana H Goodloe; S Joy Dean; Catherine Gooch; Brianna K Murray; Erin Swartz; Samantha A Schrier Vergano; Meghan C Towne; Kimberly Nugent; Elizabeth R Roeder; Christina Kresge; Beth A Pletcher; Katheryn Grand; John M Graham; Ryan Gates; Natalia Gomez-Ospina; Subhadra Ramanathan; Robin Dawn Clark; Kimberly Glaser; Paul J Benke; Julie S Cohen; Ali Fatemi; Weiyi Mu; Kristin W Baranano; Jill A Madden; Cynthia S Gubbels; Timothy W Yu; Pankaj B Agrawal; Mary-Kathryn Chambers; Chanika Phornphutkul; John A Pugh; Kate A Tauber; Svetlana Azova; Jessica R Smith; Anne O'Donnell-Luria; Hannah Medsker; Siddharth Srivastava; Deborah Krakow; Daniela N Schweitzer; Valerie A Arboleda
Journal:  Mol Genet Genomic Med       Date:  2021-09-14       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.